Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 371

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 371
---
S calculations based on 77 markers. Mean PRS values were statistically significantly different between cases and controls (p -value: 1.54e -5). The AUC was 0.62, showing moderate predictive capacity for breast cancer risk. In both studies, participant data, including health and lifestyle information, were anonymized and coded. These findings demonstrate the PRS’s potential for identifying individuals at elevated disease risk, supporting the use of these tools in preventive health. No serious adverse events occurred, and none of the collaborating institutions or sponsors are affiliates of OmnigenicsAI or its subsidiary, Heritas Argentina. Environmental, Operational Safety, and Health Regulation Our commitment to health and safety encompasses both preventive and responsive measures. We have established clear protocols for workplace safety, accident prevention, and emergency response, focusing on maintaining a secure and healthy environment. Training in fire detection, emergency coordination, and evacuation procedures ensures preparedness across the entire organization and within our facility. With a focus on safety in all aspects of operations, from everyday activities to unforeseen emergencies, our policies are aligned with the highest standards, ensuring the well -beingof all employees and stakeholders. In addition, we are committed to responsible waste management, adhering to rigorous standards in handling various types of waste, including domestic, recyclable, pathological, hazardous, and electronic. We ensure proper disposal protocols, such as secure containment and professional waste removal, aligning with environmental and safety regulations. To ensure that the samples we collect from our customers are recycled properly, we utilize a certified external waste collection service that ensures traceability and accountability, operating in full compliance with all necessary quality standards and regulatory requirements. 193 Intellectual Property We rely (and expect to rely in the future) on a combination of intellectual property rights, such as trade secrets, copyrights, trademarks and customary contractual protections, to safeguard our core technologies and intellectual property. We may also rely upon trade secret protection to protect unpatented know -howand continuing technological innovation. Trade Secrets We expect to rely in the future on trade secrets, including unpatented know -how, technology, and other proprietary information, to maintain and develop our competitive position afforded by our laboratory, analytic, and business practices. For instance, significant elements of our genetic tests and testing procedures, including aspects of specimen preparation, bioinformatics algorithms, and related processes and adaptive learning software, are based on unpatented trade secrets and know -how. We expect to take steps to keep these trade secrets and know -howconfidential, such as entering into nond